In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:

  • Burden of CRE infections in the United States
  • Mechanisms of resistance
  • Changing epidemiology
  • Use of rapid diagnostic tests
  • IDSA guidance recommendations, including supporting data
  • Approach to designing treatment regimens, including weighing patient- and infection-related factors

Faculty:

Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Link to full program: 
https://bit.ly/41a8Mj0

Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57

Link to downloadable infographic: 
https://bit.ly/3t7NpT2


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Podden och tillhörande omslagsbild på den här sidan tillhör ProCE. Innehållet i podden är skapat av ProCE och inte av, eller tillsammans med, Poddtoppen.